Viatris Innovation Gmbh

This study is testing whether a medication called selatogrel, which patients can inject themselves at home, can prevent death and reduce damage from future heart attacks. It involves 14,000 people who recently had a heart attack and have additional risk factors. Participants will…

This study aims to learn about the long-term safety and side effects of the drug cenerimod for adults with moderate-to-severe lupus. It will follow about 680 people who took part in earlier trials, giving them cenerimod along with their standard lupus medications for up to 3 year…

This study is testing if a new oral drug called cenerimod helps control symptoms when added to standard treatments for adults with moderate-to-severe lupus. About 420 participants will take either cenerimod or a placebo pill daily for one year, while continuing their usual lupus …

This early-stage study aims to measure how much of an oral dose of the experimental drug cenerimod actually gets into a person's bloodstream. Six healthy male volunteers will take a cenerimod pill and later receive a tiny, traceable intravenous dose to allow precise measurement. …